Pascal Roger
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
-
- Pituitary Gland Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Growth Hormone and Insulin-like Growth Factors
Papers in
- Oncology 31
- HER2/EGFR in Cancer Research 11
-
- Pituitary Gland Disorders and Treatments 13
- Thyroid Cancer Diagnosis and Treatment 5
- Co-authors
- Henri Rochefort (14 shared papers)Pierre Baldet (7 shared papers)Antoine Tabarin (18 shared papers)Sari Mäkelä (1 shared paper)Jan Gustafsson (1 shared paper)Thierry Maudelondé (8 shared papers)J.‐B. Corcuff (6 shared papers)Pascal Pujol (4 shared papers)
- Journals
- Clinical Endocrinology (7 papers)European Journal of Cancer (5 papers)Neuro-Oncology (4 papers)Dermatology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Pascal Roger
110 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 608
- Endocrinology, Diabetes and Metabolism 632
- Oncology 791
- Genetics 695
- Genetics 234
Countries citing papers authored by Pascal Roger
This map shows the geographic impact of Pascal Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Roger more than expected).
Fields of papers citing papers by Pascal Roger
This network shows the impact of papers produced by Pascal Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Roger. The network helps show where Pascal Roger may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Roger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. | 2001 | 409 |
| 2 | Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. | 1998 | 187 |
| 3 | 2000 | 122 | |
| 4 | 2006 | 116 | |
| 5 | 2002 | 93 | |
| 6 | 2003 | 93 | |
| 7 | 2000 | 89 | |
| 8 | 2006 | 87 | |
| 9 | 2001 | 84 | |
| 10 | 1999 | 84 | |
| 11 | 1999 | 79 | |
| 12 | 2017 | 79 | |
| 13 | 2015 | 79 | |
| 14 | 2019 | 78 | |
| 15 | 1991 | 71 | |
| 16 | 1996 | 69 | |
| 17 | 1992 | 61 | |
| 18 | 2013 | 61 | |
| 19 | 1994 | 58 | |
| 20 | 1999 | 57 |
About Pascal Roger
Pascal Roger is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Cancer Research, Pathology and Forensic Medicine and Neurology, having authored 114 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (13 papers), Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (11 papers), Breast Lesions and Carcinomas (7 papers), Glioma Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Protease and Inhibitor Mechanisms (5 papers). The work is most often cited by research in Cancer Research (608 citations), Endocrinology, Diabetes and Metabolism (632 citations), Oncology (791 citations), Genetics (695 citations) and Genetics (234 citations). Pascal Roger has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Henri Rochefort, Pierre Baldet, Antoine Tabarin, Sari Mäkelä, Jan Gustafsson, Thierry Maudelondé, J.‐B. Corcuff, Pascal Pujol, Jean‐Marc Rey and François Laffargue. Their work appears in journals such as Clinical Endocrinology, European Journal of Cancer, Neuro-Oncology, Dermatology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.